Welcome to our dedicated page for Quantumscape SEC filings (Ticker: QS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Decoding QuantumScape’s battery breakthroughs is tough. Each 10-K packed with R&D risks, every 8-K detailing pilot-line yields and the joint venture with Volkswagen, and dozens of Form 4 insider trades can overwhelm even seasoned analysts. If you have ever searched for “QuantumScape insider trading Form 4 transactions” or wondered why cash burn shifts quarter to quarter, you know the challenge.
Stock Titan solves that problem. Our AI reads every QuantumScape quarterly earnings report 10-Q filing the moment it hits EDGAR, highlights cap-ex, ceramic separator progress, and surfaces liquidity warnings so you don’t have to. Need real-time alerts for QuantumScape Form 4 insider transactions real-time? You’ll receive them in seconds. Prefer narrative explanations? Try “QuantumScape SEC filings explained simply” or ask for a “QuantumScape earnings report filing analysis” and our engine delivers point-by-point summaries, trend graphs, and contextual links.
All major documents are here, continuously updated: the QuantumScape annual report 10-K simplified to spotlight production roadmap assumptions; QuantumScape proxy statement executive compensation parsed to reveal option vesting tied to battery milestones; and every QuantumScape 8-K material events explained line by line. Whether you’re monitoring QuantumScape executive stock transactions Form 4 before key test data releases, or understanding QuantumScape SEC documents with AI for a long-term valuation model, Stock Titan’s expert analysis, AI-powered summaries, and complete filing coverage turn hundreds of pages into actionable knowledge.
Mohit Singh, Chief Development Officer of QuantumScape Corporation (QS), reported two dispositions of Class A common stock in August 2025. On 08/18/2025 he sold 41,034 shares to cover tax obligations on the release of restricted stock units at a weighted average price of $8.7024. On 08/19/2025 he sold 23,598 shares pursuant to a Rule 10b5-1 trading plan at a weighted average price of $8.6518. After these transactions he beneficially owned 1,577,079 shares, which include 1,364,273 RSUs and PSUs; RSUs vest quarterly and PSUs vest upon achievement of performance milestones. The Form 4 was signed by an attorney-in-fact on 08/20/2025.
Kevin Hettrich, Chief Financial Officer of QuantumScape (QS), reported a sale of 39,521 shares of Class A common stock on 08/18/2025 to cover tax obligations arising from the release of restricted stock units (RSUs). The weighted-average price of the shares sold was $8.7024, with individual sale prices ranging from $8.55 to $9.10. After the reported transactions, the filing shows the reporting person beneficially owned 1,611,067 shares, which include 1,260,539 shares represented by RSUs and performance restricted stock units (PSUs) and 2,500 shares acquired through the Employee Stock Purchase Plan on 06/02/2025. RSUs vest quarterly and PSUs vest upon achieving specified performance milestones, both subject to continued service.
Timothy Holme, Chief Technology Officer and director of QuantumScape Corporation (QS), reported the sale of 40,272 shares of Class A common stock on 08/18/2025 at a weighted average price of $8.7024 per share to cover tax obligations on the release of restricted stock units (RSUs). After the sale, he beneficially owns 1,621,656 shares, which include 1,364,273 RSUs and performance restricted stock units (PSUs). RSUs vest quarterly and PSUs vest upon achievement of performance milestones, both subject to continued service. The Form 4 was signed by an attorney-in-fact.
Michael O. McCarthy III, Chief Legal Officer of QuantumScape Corporation (QS), reported on Form 4 that he sold 31,766 shares of Class A common stock on 08/18/2025 at a weighted average price of $8.7024 per share to cover tax obligations arising from the release of restricted stock units (RSUs). After the sale, he beneficially owns 1,435,417 shares, which include 1,217,795 shares represented by RSUs and performance restricted stock units (PSUs). The RSUs vest quarterly while the PSUs vest upon achieving specified performance milestones, both subject to continued service.
Sivaram Srinivasan, Chief Executive Officer and Director of QuantumScape Corporation (QS), reported a transaction dated 08/18/2025 in which 84,524 shares of Class A common stock were sold at a weighted average price of $8.7024 (individual sale prices ranged from $8.55 to $9.10). The filing states the sale was to cover tax obligations on the release of restricted stock units (RSUs). After the reported sale the filing shows the reporting person beneficially owns 4,162,700 shares directly, and 450,000 shares indirectly through trusts for which he is a co-trustee. The filing also discloses that 3,802,429 of the direct shares are RSUs/PSUs that vest over time or upon performance milestones, and the Form 4 was signed by an attorney-in-fact on 08/20/2025.
QuantumScape (QS) insider Form 144 notifies a proposed sale of 23,598 common shares (RSUs) through Fidelity, with an aggregate market value of $204,165.18 and 522,939,205 shares outstanding. The shares were acquired as RSUs on the same date indicated in the notice and the planned sale is listed for 08/19/2025 on the NYSE. The filer represents there is no undisclosed material adverse information. The filing also discloses four prior sales by the same account during the past three months totaling 1,151,428 shares for aggregate gross proceeds of $8,205,925.41.
Form 144 filed for QuantumScape Corporation (QS) reports proposed and recent sales of Class A common stock by an individual identified as Mohit Singh. The filing shows a proposed sale of 47,727 shares via Morgan Stanley Smith Barney with an aggregate market value of $430,974.81 and an approximate sale date of 08/18/2025. It also discloses an acquisition of 73,425 shares on 08/15/2025 from RSU vesting, paid as compensation. During the prior three months the filer sold a total of 1,151,428 shares for aggregate gross proceeds of $8,205,925.41 across four transactions dated May through July 2025. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.
QuantumScape Corporation (QS) Form 144 notice shows a proposed sale of 100,178 Class A common shares via Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $904,607.34. The shares were acquired on 08/15/2025 upon RSU vesting and paid as compensation. The filer reports no securities sold in the past three months and affirms no undisclosed material adverse information. The filing documents the broker, estimated sale date of 08/18/2025, and total shares outstanding of 522,939,205, indicating the sale is a small fraction of outstanding stock.
QuantumScape Corporation (QS) filed a Form 144 reporting the proposed sale of 45,371 Class A common shares through Morgan Stanley Smith Barney on the NYSE with an approximate sale date of 08/18/2025. The shares were acquired by the filer on 08/15/2025 upon RSU vesting and were paid as compensation; the filing lists an aggregate market value of $409,700.13 and total shares outstanding of 522,939,205. The filing also discloses a prior sale by Michael O. McCarthy III of 500,000 shares on 07/25/2025 generating $5,798,850.00. The filer attests there is no undisclosed material adverse information.
An individual affiliated with QuantumScape Corporation (QS) filed a Form 144 to sell 46,837 shares of Class A common stock on or about 08/18/2025 through Morgan Stanley Smith Barney LLC on the NYSE. The shares were acquired on 08/15/2025 by RSU vesting and were recorded as compensation; the filer lists 72,056 shares as the amount acquired on that date. The aggregate market value of the proposed sale is $422,938.11 and total outstanding shares are shown as 522,939,205. The filer reports no sales of issuer securities in the past three months and certifies they lack undisclosed material adverse information.